Upcoming Events

7 Jun
Cubist Pharmaceuticals Annual Meeting of Stockholders
Thursday Jun. 7th 2012
11 Jun
Cubist Pharmaceuticals’ Product Pipeline Investor and Analyst Event
Monday Jun. 11th 2012
18 Jun
2012 BIO International Convention
Monday Jun. 18th 2012

View All Upcoming Events

News & Media

Superbugs - The threat is real.

Press Releases View All

5/16/2012

Cubist Pharmaceuticals Marks 20th Anniversary by Making Its Largest-Ever Commitment to STEM Programs
5/14/2012

Cubist Announces First Scientific Presentations of Phase 2 Data for CB-5945 in the Treatment of Opioid-Induced Constipation
5/7/2012

Cubist Pharmaceuticals to Present at May Investor Conference
4/18/2012

Cubist Pharmaceuticals Reports First Quarter 2012 Financial Results
4/17/2012

Cubist Announces Positive Results from ENTEREG® Phase 4 Study in Patients Undergoing Radical Cystectomy
4/2/2012

Cubist Pharmaceuticals to Announce Q112 Financial Results on Wednesday, April 18th, 2012
3/16/2012

Cubist Opens Expanded Research and Development Facility
3/9/2012

Cubist Pharmaceuticals Appoints Jane Henney to Board of Directors
2/20/2012

Cubist Pharmaceuticals to Present at February/March Investor Conferences
2/16/2012

Cubist Pharmaceuticals Appoints Alison Lawton to Board of Directors

Cubist in the News View All

Media Contact

At Cubist:

Francis McLoughlin
Director, Corporate Communications
(781) 860-8777
francis.mcloughlin@cubist.com